Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

The latest 8-K info did not help matters

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
x1power Member Profile
 
Followed By 31
Posts 1,389
Boards Moderated 0
Alias Born 10/01/12
160x600 placeholder
Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System GlobeNewswire Inc. - 7/16/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 4:52:01 PM
Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt GlobeNewswire Inc. - 7/10/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2019 4:10:14 PM
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Devi... GlobeNewswire Inc. - 6/24/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 6:02:09 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 6/21/2019 5:24:09 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/13/2019 4:08:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/13/2019 4:03:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 12:28:00 PM
Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire Inc. - 6/10/2019 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/7/2019 5:05:43 PM
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire Inc. - 6/4/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 7:16:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/3/2019 7:16:05 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/31/2019 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 5:12:26 PM
Under the Radar Biotechs To Research Now InvestorsHub NewsWire - 5/30/2019 1:40:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/30/2019 6:09:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/30/2019 6:05:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2019 5:23:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/28/2019 6:05:25 AM
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire Inc. - 5/23/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 4:52:11 PM
Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire Inc. - 5/21/2019 4:01:00 PM
x1power   Friday, 01/04/19 11:28:02 AM
Re: Chunky Salsa post# 68
Post # of 351 
The latest 8-K info did not help matters either, on top of coming new funding announcements.

TA seems to indicate lower entry stock price possibilities to present.
Also with lower current stock volume interest and Government funding impasse effects, down=trend to continue.
Who amongst the 800K government employees and plus contractors . . .
who will probably not be jumping to get operative procedures in 1st Q 2019.





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist